Folgen
Sofia A Pereira
Sofia A Pereira
Nova Medical School - Universidade NOVA Lisboa Portugal
Bestätigte E-Mail-Adresse bei nms.unl.pt
Titel
Zitiert von
Zitiert von
Jahr
Anti-angiogenic therapy: current challenges and future perspectives
F Lopes-Coelho, F Martins, SA Pereira, J Serpa
International journal of molecular sciences 22 (7), 3765, 2021
1882021
Cysteine metabolic circuitries: Druggable targets in cancer
VDB Bonifácio, SA Pereira, J Serpa, JB Vicente
British journal of cancer 124 (5), 862-879, 2021
1352021
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
SC Nunes, C Ramos, F Lopes-Coelho, CO Sequeira, F Silva, ...
Scientific reports 8 (1), 9513, 2018
682018
HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)
F Lopes-Coelho, S Gouveia-Fernandes, LG Gonçalves, C Nunes, ...
Tumor Biology 37, 4813-4829, 2016
652016
Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using …
W Kromdijk, SA Pereira, H Rosing, JW Mulder, JH Beijnen, ADR Huitema
Journal of Chromatography B 919, 43-51, 2013
562013
Evidence for nevirapine bioactivation in man: searching for the first step in the mechanism of nevirapine toxicity
U Caixas, AMM Antunes, AT Marinho, ALA Godinho, NM Grilo, ...
Toxicology 301 (1-3), 33-39, 2012
502012
Targeting glutathione and cystathionine β-synthase in ovarian cancer treatment by selenium–chrysin polyurea dendrimer nanoformulation
I Santos, C Ramos, C Mendes, CO Sequeira, CS Tomé, DGH Fernandes, ...
Nutrients 11 (10), 2523, 2019
442019
Monocytes as endothelial progenitor cells (EPCs), another brick in the wall to disentangle tumor angiogenesis
F Lopes-Coelho, F Silva, S Gouveia-Fernandes, C Martins, N Lopes, ...
Cells 9 (1), 107, 2020
402020
Usefulness of zebrafish larvae to evaluate drug-induced functional and morphological renal tubular alterations
R Gorgulho, R Jacinto, SS Lopes, SA Pereira, EM Tranfield, GG Martins, ...
Archives of toxicology 92 (1), 411-423, 2018
362018
Differences in nevirapine biotransformation as a factor for its sex-dependent dimorphic profile of adverse drug reactions
AT Marinho, PM Rodrigues, U Caixas, AMM Antunes, T Branco, ...
Journal of antimicrobial chemotherapy 69 (2), 476-482, 2014
362014
Long‐term and concentration‐dependent beneficial effect of efavirenz on HDL‐cholesterol in HIV‐infected patients
SA Pereira, T Branco, RM Côrte‐Real, I Germano, F Lampreia, U Caixas, ...
British journal of clinical pharmacology 61 (5), 601-604, 2006
362006
Voluntary oral administration of losartan in rats
LN Diogo, IV Faustino, RA Afonso, SA Pereira, EC Monteiro, AI Santos
Journal of the American Association for Laboratory Animal Science 54 (5 …, 2015
342015
Reactive aldehyde metabolites from the anti-HIV drug abacavir: amino acid adducts as possible factors in abacavir toxicity
C Charneira, ALA Godinho, MC Oliveira, SA Pereira, EC Monteiro, ...
Chemical research in toxicology 24 (12), 2129-2141, 2011
342011
Hepatocyte spheroids as a competent in vitro system for drug biotransformation studies: nevirapine as a bioactivation case study
PF Pinheiro, SA Pereira, SG Harjivan, IL Martins, AT Marinho, M Cipriano, ...
Archives of toxicology 91, 1199-1211, 2017
322017
Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms
NM Grilo, MJ Correia, JP Miranda, M Cipriano, J Serpa, MM Marques, ...
European Journal of Pharmaceutical Sciences 105, 47-54, 2017
312017
Monitoring abacavir bioactivation in humans: screening for an aldehyde metabolite
NM Grilo, AMM Antunes, U Caixas, AT Marinho, C Charneira, MC Oliveira, ...
Toxicology letters 219 (1), 59-64, 2013
312013
Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer
SC Nunes, F Lopes-Coelho, S Gouveia-Fernandes, C Ramos, SA Pereira, ...
BMC Evolutionary Biology 18, 1-17, 2018
302018
Implications of sulfotransferase activity in interindividual variability in drug response: clinical perspective on current knowledge
N Marto, J Morello, EC Monteiro, SA Pereira
Drug metabolism reviews 49 (3), 357-371, 2017
292017
Bioactivation to an aldehyde metabolite—possible role in the onset of toxicity induced by the anti-HIV drug abacavir
NM Grilo, C Charneira, SA Pereira, EC Monteiro, MM Marques, ...
Toxicology letters 224 (3), 416-423, 2014
292014
Efavirenz concentrations in HIV‐infected patients with and without viral hepatitis
SA Pereira, U Caixas, T Branco, I Germano, F Lampreia, AL Papoila, ...
British journal of clinical pharmacology 66 (4), 551-555, 2008
282008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20